Skip to main content
Karol Watson, MD, Cardiology, Los Angeles, CA

KarolElizabethWatsonMD

Cardiology Los Angeles, CA

Adult Congenital Heart Disease

Co-director, UCLA Program in Preventive Cardiology

Dr. Watson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Watson's full profile

Already have an account?

  • Office

    200 Medical Plaza
    365530420120
    Los Angeles, CA 90095
    Phone+1 310-825-8811
    Fax+1 310-206-9133

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1992 - 1998
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1992
  • Harvard Medical School
    Harvard Medical SchoolClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2026
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older Adults  
    Alain Bertoni, Gerard Criner, Mark T Dransfield, Meilan K Han, Nadia N Hansel, Erin D Michos, Elizabeth C Oelsner, Karol E Watson, JAMA
  • A Reference Set of Curated Biomedical Data and Metadata from Clinical Case Reports  
    Shaun P Setty, Karol E Watson, Nature
  • Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study  
    Edward J Boyko, Karol E Watson, Ana C Ricardo, The Journal of Clinical Endocrinology and Metabolism
  • Join now to see all

Lectures

  • PCSK-9 Inhibitors Appropriate Use and Benefits Application in Minority Populations 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • New Paradigms in Contemporary Cardiovascular Care: Application of Guideline-Directed Therapies Im plications for Minority Populations and Resolution of Dispariti... 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Interleukin-10 as a Predictor of Major Adverse Cardiovascular Events in a Racially and Ethnically Diverse Population: Multi-Ethnic Study of Atherosclerosis 
    Contemporary Forums, Jackson Hole, Wyoming - 7/29/2012

Authored Content

  • Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older AdultsJune 2020
  • For Stable Chest Pain, CCTA Evaluation Lowers Longer-Term RiskAugust 2018

Press Mentions

  • What You Need to Know About Blood Thinners
    What You Need to Know About Blood ThinnersNovember 15th, 2024
  • Prevalence and Outcomes of Persistent Hypertension Postpartum in Women with a Hypertensive Disorder of Pregnancy
    Prevalence and Outcomes of Persistent Hypertension Postpartum in Women with a Hypertensive Disorder of PregnancyAugust 19th, 2024
  • Promising First Results with DNA Editing to Lower LDL
    Promising First Results with DNA Editing to Lower LDLNovember 20th, 2023
  • Join now to see all

Professional Memberships

Other Languages

  • Italian, Spanish